Emcure Pharma Shares Hit 10% Upper Circuit as Q2 Profit Rises
Emcure Pharmaceuticals reported an increase in consolidated net profit to ₹325.06 crore for the September quarter. Its shares rose 10% to the upper circuit on Wednesday.
Emcure Pharmaceuticals shares rallied 10 per cent to hit the upper circuit on Wednesday after the company reported a 29.31 per cent increase in consolidated net profit to ₹325.06 crore in the September quarter, supported by strong growth in its international business.Shares rallied 10%The quarterly…